entity

TDP-43_phase_separation

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TDP-43_phase_separation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
3Hypotheses
1Analyses
0Outgoing
1Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (1)

SourceRelationTypeStr
glycine-rich_domainactivatesprotein0.80

Targeting Hypotheses (3)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
RNA-binding protein condensate maturation from reversible ph 0.626 neurodegeneration Biophysical Determinants Shifting FUS/TD
Cell-state stratification is required to resolve Biophysical 0.612 neurodegeneration Biophysical Determinants Shifting FUS/TD
Perturbation-first validation should precede therapeutic cla 0.608 neurodegeneration Biophysical Determinants Shifting FUS/TD

Mentioning Analyses (1)

Scientific analyses that reference this entity

TDP-43 phase separation therapeutics for ALS-FTD

neurodegeneration | 2026-04-01 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

What are the mechanisms underlying tdp-43 phase separation therapeutics for als-

closed · Rounds: 4 · Score: 0.95 · 2026-04-01

Related Research

Hypotheses and analyses mentioning TDP-43_phase_separation in their description or question text

No additional research found